Thai Hau Koo

Dr. Thai Hau Koo

Internal Medicine, Hospital Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HBHareesha Rishab Bharadwaj
Hareesha Rishab Bharadwaj
Thai Hau KooThai Hau Koo
Thai Hau Koo
DDDushyant Singh Dahiya
Dushyant Singh Dahiya
PDPriyal Dalal
Priyal Dalal
MFMuhtasim Fuad
Muhtasim Fuad
AIAnthony Infantolino
Anthony Infantolino
Motility disorders, particularly gastroparesis, are prevalent complications following solid organ transplantation, significantly impacting quality of life, nutritional status, graft survival, and mortality. This comprehensive review synthesises evidence from PubMed, Scopus, and Embase databases on pathophysiology, clinical manifestations, diagnosis, management, and prognostic factors across transplant types. Mechanisms include vagal nerve injury (highest in lung transplants, prevalence 40–91%), immunosuppressive effects (e.g., tacrolimus accelerates motility; mycophenolate impairs it), surgical trauma, microbiome dysbiosis (reduced Firmicutes/Bacteroidetes ratio), and metabolic factors like post-transplant diabetes (OR 5.17 in kidney recipients). Pediatric and thoracic recipients face the highest risks, with lung transplant gastroparesis conferring a 2.7-fold increased mortality/retransplantation hazard (p < 0.05). Diagnosis relies on gastric emptying scintigraphy (gold standard, sensitivity 85–95%) and wireless motility capsules (100% sensitivity for delay), while management encompasses prokinetics (60–80% response), endoscopic G-POEM (85% success), gastric electrical stimulation (100% quality-of-life improvement in series), and nutritional support. Prognostic factors include younger age (better intervention response), aetiology (anatomical worse than metabolic), and early therapy success. Outcomes vary: lung recipients experience severe impacts on chronic allograft dysfunction (83% oesophageal motility abnormalities correlate with 66–67% rejection). Future directions emphasise microbiome therapies, AI predictive models (AUC 0.85), and wearables for continuous monitoring. Multidisciplinary approaches are essential to balance immunosuppression with GI management, addressing ethical dilemmas like drug interactions and access disparities. Ultimately, early screening and personalised interventions can mitigate complications, enhancing long-term transplant success.

1 November 2024 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
Thai Hau KooThai Hau Koo
Thai Hau Koo
Andee Dzulkarnaen ZakariaAndee Dzulkarnaen Zakaria
Andee Dzulkarnaen Zakaria
ZMZulkifli Mustafa
Zulkifli Mustafa
Context: Honey has been employed for its therapeutic attributes since ancient eras, with a history of medicinal utilization, and recent studies have highlighted its diverse clinical applications. The medicinal benefits of honey can be ascribed to various mechanisms, encompassing its osmotic and acidic characteristics, hydrogen peroxide generation, and particular bioactive compounds. While honey generally has a good safety profile, rare risks exist, particularly in infants under one year of age. More rigorous clinical trials and standardized protocols are needed to establish its optimal dosage, application methods, and specific indications. Economic considerations and regional variations in honey composition and quality should also be considered. Aims: To provide an overview of the clinical uses of honey in the medical field, emphasizing its effectiveness and potential therapeutic benefits. Methods: A comprehensive literature search was conducted to gather relevant studies on the clinical applications of honey. The search encompassed various databases and included studies published with the range from May 2001 to May 2023. The selected studies were critically reviewed to extract pertinent information for this critical review. Results: Natural honey comes from two types of honey-producing bees: honeybees and stingless bees. Honey constitutes a multifaceted amalgamation of sugars, enzymes, minerals, vitamins, and bioactive compounds, all contributing to its therapeutic attributes. It exhibits antibacterial, anti-inflammatory, wound healing, and antioxidant effects. In wound management, honey promotes healing, reduces infection rates, and minimizes scarring. It also shows promise in treating bacterial and fungal infections. Furthermore, honey has effectively alleviated symptoms associated with respiratory tract infections, gastrointestinal disorders, and dermatological conditions. Conclusions: Honey possesses multifaceted clinical applications in the medical field. Its diverse therapeutic properties and minimal adverse effects make it an attractive option for various conditions. However, further research is necessary to solidify its role in evidence-based clinical practice, including conducting more rigorous clinical trials, establishing standardized protocols, and considering economic and regional factors.


1 September 2023 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
Yeong Yeh LeeYeong Yeh Lee
Yeong Yeh Lee
NRNur Sakinah Roslan
Nur Sakinah Roslan
VTVincent Tee
Vincent Tee
Thai Hau KooThai Hau Koo
Thai Hau Koo
YIYusof Shuaib Ibrahim
Yusof Shuaib Ibrahim

29 March 2024 in Education in Medicine Journal
Verified
Journal Article
Closed access
Thai Hau KooThai Hau Koo
Thai Hau Koo
VTVincent Tee
Vincent Tee
GKGarry Kuan
Garry Kuan

Verified
Journal Article
Open access
PDF file
RRRocky Vester Richmond
Rocky Vester Richmond
UMUMA MAGESWARY MAGESWARAN
UMA MAGESWARY MAGESWARAN
Adli AliAdli Ali
Adli Ali
FTFahisham Taib
Fahisham Taib
Thai Hau KooThai Hau Koo
Thai Hau Koo
MLMin Tze Liong
Min Tze Liong
Respiratory tract and gastrointestinal infections in pediatric populations are major public health concerns. Addressing these challenges necessitates effective preventative and therapeutic strategies. This study assessed the efficacy of the probiotic Bifidobacterium longum subsp. infantis B8762 (0.5 × 1010 CFU) in reducing the duration and frequency of these infections in young children. In a randomized trial, 115 eligible children were assigned to either the probiotic (n = 57; 3.51 ± 0.48 months old) or placebo (n = 58; 2.78 ± 0.51 months old) group, with daily consumption for 4 weeks. The probiotic group demonstrated a lower duration of infections than the placebo group (p < 0.05). The probiotic group also showed fewer clinical visits due to respiratory and gastrointestinal problems as compared to the placebo group (p = 0.009 & p = 0.004, respectively). Oral swab samples revealed that the placebo group had higher levels of pro-inflammatory cytokine TNF-α after 4 weeks (p = 0.033), while the probiotic group demonstrated a balanced cytokine response, indicating modulation of the immune system. Genomic analysis showed that B8762 harbors various genes for the synthesis of proteins and vitamins crucial for the gut health of children. Both the clinical and genomic findings suggested that B8762 offered a therapeutic effect on gut and respiratory health in children, highlighting its potential in managing common pediatric infections.